Schiff et al. (2021) demonstrated that NK-92 cells engineered to express a CAR targeting epidermal growth factor receptor (EGFR) exhibited potent cytotoxic effects against ATC cell lines in vitro and significantly reduced tumor growth in xenograft models [31]. Here, EGFR is linked to neoplasm.